Effectiveness of pulmonary rehabilitation on quality of life and exercise tolerance in post tuberculosis lung disease

Background PTLD (Post-Tuberculosis Lung Disease) is one of the most frequent long-term complications of pulmonary tuberculosis which features persistent respiratory problems, low tolerance to physical activity, poor lung function and poor HRQoL (Health-Related Quality of Life). Pulmonary Rehabilitation (PR) appears to be one of the possible treatment methods for PTLD patients, although its efficacy still needs to be proved. Objective The objective of the study was to systematically assess the efficacy of pulmonary rehabilitation programs in increasing exercise tolerance and functional status among PTLD patients. Methods The meta-analysis is based on the PRISMA guidelines. The electronic databases (PubMed, Embase, ProQuest, and Google Scholar) was scanned up until June 2025. Studies with adult patients with PTLD undergoing pulmonary rehabilitation were selected. Exercise capacity and HRQoL were considered primary outcomes, while secondary outcomes were pulmonary function parameters. The random effect model was used for the meta-analysis in order to compute the SMD with 95% CIs. Results Fourteen articles involving 649 participants met the inclusion criteria. The meta-analysis demonstrated statistically significant improvements across all objective pulmonary function parameters following pulmonary rehabilitation: FEV 1 -6 studies, n = 490 (SMD = 0.452, 95% CI: −0.108 to 0.796, p = 0.010), FVC-6 studies, n = 490 (SMD = 0.319, 95% CI: −0.066 to 0.572, p = 0.013), and FEV 1 /FVC ratio-6 studies, n = 490 (SMD = 0.476, 95% CI: −0.091 to 0.861, p = 0.015). Furthermore, functional capacity measured by the 6-Minute Walk Test showed a large, highly significant improvement (7 studies, n = 550, SMD = 1.615, 95% CI: 0.856 to 2.373, p < 0.00). Pooled health-related quality of life (HRQoL) did not reach statistical significance (5 studies, n = 302, SMD=0.374, CI: −1.353 to 2.102, p = 0.671), which was driven by extreme methodological heterogeneity arising from combining opposing generic (SF-36) and disease-specific (SGRQ) scale directionality structures Conclusions Pulmonary rehabilitation is a highly effective non-pharmacological treatment strategy for patients with PTLD, offering substantial, clinically meaningful improvements in functional exercise capacity (6 MWT) alongside objective, statistically significant improvements in spirometric parameters. These findings strongly support the systematic integration of pulmonary rehabilitation into long-term post-tuberculosis management and national TB control programs. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/view/CRD420251080647 , identifier CRD420251080647.

Authors

Publication Details

Journal
Frontiers in Rehabilitation Sciences
Published
2026-11-17
DOI
https://doi.org/10.3389/fresc.2026.1944982
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effectiveness of pulmonary rehabilitation on quality of life and exercise tolerance in post tuberculosis lung disease

Srikanta Kanungo, Rachita Mukherjee, Sanghamitra Pati, K. Poornima et al.
2 links
Frontiers in Rehabilitation Sciences
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Effectiveness of pulmonary rehabilitation on quality of life and exercise tolerance in post tuberculosis lung disease

Srikanta Kanungo, Rachita Mukherjee, Sanghamitra Pati, K. Poornima, Bishwajit Singh
article en

Abstract

Background PTLD (Post-Tuberculosis Lung Disease) is one of the most frequent long-term complications of pulmonary tuberculosis which features persistent respiratory problems, low tolerance to physical activity, poor lung function and poor HRQoL (Health-Related Quality of Life). Pulmonary Rehabilitation (PR) appears to be one of the possible treatment methods for PTLD patients, although its efficacy still needs to be proved. Objective The objective of the study was to systematically assess the efficacy of pulmonary rehabilitation programs in increasing exercise tolerance and functional status among PTLD patients. Methods The meta-analysis is based on the PRISMA guidelines. The electronic databases (PubMed, Embase, ProQuest, and Google Scholar) was scanned up until June 2025. Studies with adult patients with PTLD undergoing pulmonary rehabilitation were selected. Exercise capacity and HRQoL were considered primary outcomes, while secondary outcomes were pulmonary function parameters. The random effect model was used for the meta-analysis in order to compute the SMD with 95% CIs. Results Fourteen articles involving 649 participants met the inclusion criteria. The meta-analysis demonstrated statistically significant improvements across all objective pulmonary function parameters following pulmonary rehabilitation: FEV 1 -6 studies, n = 490 (SMD = 0.452, 95% CI: −0.108 to 0.796, p = 0.010), FVC-6 studies, n = 490 (SMD = 0.319, 95% CI: −0.066 to 0.572, p = 0.013), and FEV 1 /FVC ratio-6 studies, n = 490 (SMD = 0.476, 95% CI: −0.091 to 0.861, p = 0.015). Furthermore, functional capacity measured by the 6-Minute Walk Test showed a large, highly significant improvement (7 studies, n = 550, SMD = 1.615, 95% CI: 0.856 to 2.373, p < 0.00). Pooled health-related quality of life (HRQoL) did not reach statistical significance (5 studies, n = 302, SMD=0.374, CI: −1.353 to 2.102, p = 0.671), which was driven by extreme methodological heterogeneity arising from combining opposing generic (SF-36) and disease-specific (SGRQ) scale directionality structures Conclusions Pulmonary rehabilitation is a highly effective non-pharmacological treatment strategy for patients with PTLD, offering substantial, clinically meaningful improvements in functional exercise capacity (6 MWT) alongside objective, statistically significant improvements in spirometric parameters. These findings strongly support the systematic integration of pulmonary rehabilitation into long-term post-tuberculosis management and national TB control programs. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/view/CRD420251080647 , identifier CRD420251080647.

Frontiers in Rehabilitation SciencesVol. 7
Good health and well-being
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon